Research and development

Rolls-Royce Holdings plc Monitor

Rolls-Royce Holdings plc Annual Report 2017
CR Monitor Issue: 
2018/0715
Company covered: 
Rolls-Royce Holdings plc
Period End: 
31 December, 2017
Report issued on 17 July 2018 covered the following practice issues:
Pronouncements
Enhanced disclosure with respect to new accounting standards including quantification in respect of IFRS 15 "Revenues from contracts with customers".
Change
Disclosure of a reduction in the number of reporting segments linked to business simplification.
Change
Enhanced disclosure in respect of capitalisation of internally generated development costs.
Restatement
Restatement of comparative lease amount linked to correction in exchange rate applied.
Change
Bargain purchase gain recognised in respect of step acquisition.
Change
Additional deferred tax asset recognised following a change in UK tax law.

Micro Focus International plc Monitor

Micro Focus International plc Annual Report 2017
CR Monitor Issue: 
2018/0204
Company covered: 
Micro Focus International plc
Period End: 
30 April, 2017
Report issued on 13 February 2018 covered the following practice issues:
Change
Amortisation of capitalised research and development costs reclassified to cost of sales to achieve comparability.
Change
Goodwill recognised on business acquisition represents value of the assembled workforce and expected future economic benefits.
Pronouncements
Disclosures on amendments to IFRS 2.
Pronouncements
Qualitative disclosures on the future impacts of new revenue standard.
Change
Risk disclosures enhanced by inclusion of flow chart illustrating the risk management cycle.
Change
Disclosure of principal risk factors extended to identify competition as a new risk factor.

Imagination Technologies Group plc Monitor

Imagination Technologies Group plc Annual Report 2016
CR Monitor Issue: 
2017/0410
Company covered: 
Imagination Technologies Group plc
Period End: 
30 April, 2016
Report issued on 25 April 2017 covered the following practice issues:
Change
Breach of a covenant of a borrowing facility results in re-classification of a liability as current.
Change
Discussion of going concern assumption includes reference to covenant breach.
Change
Disclosure of principal risks extended to include discussion of covenant breach.
Change
Income statement format altered with "separately disclosable items" highlighted in a separate column.
Restatement
Research and development disclosure restated following a more appropriate cost allocation.
New
Separate disclosure of movements in provisions introduced.

R&D tax and expenditure credits: an emerging issue under IFRS

This report addresses accounting for the new research and development (R&D) expenditure credit (RDEC) available from Her Majesty's Revenue and Customs (HMRC), the responsible tax authority in the United Kingdom, the previous UK scheme still in force for some companies and a similar scheme in Europe.

WS Atkins plc Group Monitor

WS Atkins plc Group Annual Report 2015
CR Monitor Issue: 
2015/1009
Company covered: 
WS Atkins plc Group
Period End: 
31 March, 2015
Report issued on 29 October 2015 covered the following practice issues:
Change
R&D tax credits offset against relevant expenditure rather than through tax, but without restatement.
Pronouncements
Some joint arrangements classified as joint operations, on adoption of new consolidation Standards.

Novo Nordisk A/S Monitor

Novo Nordisk A/S Annual Report 2014
CR Monitor Issue: 
2015/0404
Company covered: 
Novo Nordisk A/S
Period End: 
31 December 2014
Report issued on 07 April 2015 covered the following practice issues:
Change
Research and development costs analysed by nature and segment.
Change
Changes to disaggregation of forward contracts and derivative movements.
Change
Favorable impact of securitisation arrangement on liquidity disclosed.
Change
Interpretative commentary interleaved with financial statements.

Research and development - Bayer AG

Period End: 
31 December 2013
Period End Date: 
2013-12-31
Listing Status: 
S&P Europe 350
ICB Industry Classification: 
1353 Commodity Chemicals
Auditor: 
PricewaterhouseCoopers

Research and development - Bombardier

Period End: 
31 December 2013
Period End Date: 
2013-12-31
Listing Status: 
Listed
ICB Industry Classification: 
2713 Aerospace
Auditor: 
Ernst & Young

Research and development - Koninklijke Philips NV

Period End: 
31 December 2013
Period End Date: 
2013-12-31
Listing Status: 
S&P Europe 350
ICB Industry Classification: 
3743 Consumer Electronics
Auditor: 
KPMG